Low-dose IL-2 therapy compensates for metabolic shifts and reverses anxiety-like behavior in PD-1 deficiency-induced autoimmunity.
作者信息
Lv Cui, Zhang Hao, Li Zifa, Zhang Hao, Zhang Yu, Li Ronghui, Wei Sheng, Yu Di
机构信息
School of Pharmaceutical Sciences, Shandong Analysis and Test Center, Laboratory of Immunology for Environment and Health, Qilu University of Technology (Shandong Academy of Sciences), Jinan, Shandong, China.
Experimental Center, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
出版信息
Cell Mol Immunol. 2021 May;18(5):1336-1338. doi: 10.1038/s41423-020-00562-y. Epub 2020 Oct 16.
Abstract
摘要
相似文献
1
Low-dose IL-2 therapy compensates for metabolic shifts and reverses anxiety-like behavior in PD-1 deficiency-induced autoimmunity.低剂量白细胞介素-2疗法可补偿代谢变化，并逆转PD-1缺乏诱导的自身免疫中的焦虑样行为。
Cell Mol Immunol. 2021 May;18(5):1336-1338. doi: 10.1038/s41423-020-00562-y. Epub 2020 Oct 16.
2
Metabolic shift induced by systemic activation of T cells in PD-1-deficient mice perturbs brain monoamines and emotional behavior.在 PD-1 缺陷小鼠中系统性激活 T 细胞引起的代谢转变扰乱了脑单胺和情绪行为。
Nat Immunol. 2017 Dec;18(12):1342-1352. doi: 10.1038/ni.3867. Epub 2017 Oct 23.
3
PD-1 and autoimmunity.程序性死亡受体1（PD-1）与自身免疫
Crit Rev Immunol. 2011;31(4):265-95. doi: 10.1615/critrevimmunol.v31.i4.10.
4
Dexamethasone enhances programmed cell death 1 (PD-1) expression during T cell activation: an insight into the optimum application of glucocorticoids in anti-cancer therapy.地塞米松在T细胞活化过程中增强程序性细胞死亡蛋白1（PD-1）的表达：深入了解糖皮质激素在抗癌治疗中的最佳应用。
BMC Immunol. 2015 Jun 26;16:39. doi: 10.1186/s12865-015-0103-2.
5
Interleukin-2 reverses the defect in activation-induced apoptosis in T cells from autoimmune lpr mice.白细胞介素-2可逆转自身免疫性lpr小鼠T细胞中激活诱导的凋亡缺陷。
Cell Immunol. 1998 Jan 10;183(1):1-12. doi: 10.1006/cimm.1997.1233.
6
Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo.白细胞介素-2在体内增强抗病毒T细胞反应的治疗用途。
Nat Med. 2003 May;9(5):540-7. doi: 10.1038/nm866. Epub 2003 Apr 14.
7
The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands.常见的γ链细胞因子白细胞介素-2、白细胞介素-7、白细胞介素-15和白细胞介素-21可诱导程序性死亡-1及其配体的表达。
J Immunol. 2008 Nov 15;181(10):6738-46. doi: 10.4049/jimmunol.181.10.6738.
8
A Small Molecule Antagonist of PD-1/PD-L1 Interactions Acts as an Immune Checkpoint Inhibitor for NSCLC and Melanoma Immunotherapy.一种 PD-1/PD-L1 相互作用的小分子拮抗剂可作为 NSCLC 和黑色素瘤免疫治疗的免疫检查点抑制剂。
Front Immunol. 2021 May 14;12:654463. doi: 10.3389/fimmu.2021.654463. eCollection 2021.
9
PD-1 Imposes Qualitative Control of Cellular Transcriptomes in Response to T Cell Activation.PD-1 对 T 细胞激活做出细胞转录组学的定性控制。
Mol Cell. 2020 Mar 5;77(5):937-950.e6. doi: 10.1016/j.molcel.2019.12.012. Epub 2020 Jan 8.
10
PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells.PD-L1 阻断与 IL-2 治疗协同作用，重新激活衰竭的 T 细胞。
J Clin Invest. 2013 Jun;123(6):2604-15. doi: 10.1172/JCI67008. Epub 2013 May 15.
引用本文的文献
1
Low-dose IL-2 Treatment Rescues Cognitive Deficits by Repairing the Imbalance Between Treg and Th17 Cells at the Middle Alzheimer's Disease Stage.低剂量白细胞介素 2 治疗通过修复阿尔茨海默病中期 Treg 和 Th17 细胞失衡来挽救认知缺陷。
J Neuroimmune Pharmacol. 2023 Dec;18(4):674-689. doi: 10.1007/s11481-023-10090-x. Epub 2023 Nov 14.
2
The effect of combining PD-1 agonist and low-dose Interleukin-2 on treating systemic lupus erythematosus.PD-1 激动剂联合低剂量白细胞介素 2 治疗系统性红斑狼疮的疗效。
Front Immunol. 2023 Mar 8;14:1111005. doi: 10.3389/fimmu.2023.1111005. eCollection 2023.
3
Using phenotype risk scores to enhance gene discovery for generalized anxiety disorder and posttraumatic stress disorder.利用表型风险评分增强广泛性焦虑障碍和创伤后应激障碍的基因发现。
Mol Psychiatry. 2022 Apr;27(4):2206-2215. doi: 10.1038/s41380-022-01469-y. Epub 2022 Feb 18.
4
Jie-Yu-He-Huan Capsule Ameliorates Anxiety-Like Behaviours in Rats Exposed to Chronic Restraint Stress via the cAMP/PKA/CREB/BDNF Signalling Pathway.解郁合欢胶囊通过 cAMP/PKA/CREB/BDNF 信号通路改善慢性束缚应激大鼠的焦虑样行为。
Oxid Med Cell Longev. 2021 Oct 4;2021:1703981. doi: 10.1155/2021/1703981. eCollection 2021.
Zotero 插件